442 related articles for article (PubMed ID: 33587978)
1. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
Lin Z; Xie X; Lu S; Liu T
Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
[TBL] [Abstract][Full Text] [Related]
2. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA.
Chen H; Gong Z; Zhou H; Han Y
Drug Dev Res; 2024 Apr; 85(2):e22167. PubMed ID: 38444106
[TBL] [Abstract][Full Text] [Related]
3. Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance.
Qin S; Wang Y; Ma C; Lv Q
Eur J Med Res; 2023 Sep; 28(1):354. PubMed ID: 37717007
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics.
Fuloria S; Yadav G; Menon SV; Ali H; Pant K; Kaur M; Deorari M; Sekar M; Narain K; Kumar S; Fuloria NK
Pathol Res Pract; 2024 Jul; 259():155346. PubMed ID: 38781762
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
[TBL] [Abstract][Full Text] [Related]
7. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
Lin Z; Lu S; Xie X; Yi X; Huang H
Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.
Wang C; Jing J; Cheng L
Invest New Drugs; 2018 Dec; 36(6):1116-1132. PubMed ID: 30079443
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2.
Wen JF; Jiang YQ; Li C; Dai XK; Wu T; Yin WZ
Cancer Biomark; 2020; 28(2):231-246. PubMed ID: 32508321
[TBL] [Abstract][Full Text] [Related]
10. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance.
Zhu KP; Zhang CL; Ma XL; Hu JP; Cai T; Zhang L
Mol Ther; 2019 Mar; 27(3):518-530. PubMed ID: 30692017
[TBL] [Abstract][Full Text] [Related]
11. Long Non-coding RNAs in Cisplatin Resistance in Osteosarcoma.
Ferretti VA; León IE
Curr Treat Options Oncol; 2021 Mar; 22(5):41. PubMed ID: 33745006
[TBL] [Abstract][Full Text] [Related]
12. Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-184 Modulates Doxorubicin Resistance in Osteosarcoma Cells by Targeting BCL2L1.
Lin BC; Huang D; Yu CQ; Mou Y; Liu YH; Zhang DW; Shi FJ
Med Sci Monit; 2016 May; 22():1761-5. PubMed ID: 27222034
[TBL] [Abstract][Full Text] [Related]
15. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
Wang M; Yu F; Chen X; Li P; Wang K
Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
[TBL] [Abstract][Full Text] [Related]
16. An update on the roles of circular RNAs in osteosarcoma.
Li Z; Li X; Xu D; Chen X; Li S; Zhang L; Chan MTV; Wu WKK
Cell Prolif; 2021 Jan; 54(1):e12936. PubMed ID: 33103338
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
18. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
Han Z; Shi L
Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
[TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.
Chen D; Liu D; Chen Z
Tumour Biol; 2017 Sep; 39(9):1010428317705762. PubMed ID: 28933259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]